idiopathic anaphylaxis information center

a resource for people with ia and other mast cell disorders

References

Introduction | A — B | C — D | E — F | G — H | I — K | L — M | N — O | P — R | S | T — V | W — Z |

Note

 
Search this site

Links:

Graphic of treasure map linked to Site Map page

Saff RH, Fink JN. Anaphylaxis to chicken soup: A case report and a brief history of the chicken in medicine. J Allergy Clin Immunol. 1992; 89:1061–2

Saito H, Okayama Y, eds. Mast Cells in Allergic Disease. Chem Immunol Allergy, Vol. 87. New York, NY: Karger; 2005.

Saito H. Progress in allergy signal research on mast cells: Systemic approach to mast cell biology in allergic diseases. J Pharmacol Sci. 2008; 106,341–346.

Sala A, Labrador-Horrillo M, Guilarte M, Luengo O, Rueda M, Cardona V. Immediate-type hypersensitivity reaction to levothyroxine and desensitization [letter]. Ann Allergy Asthma Immunol. 2008; 100:513–4.

Salberg DJ. Idiopathic anaphylaxis and histamine levels [letter]. Arch Intern Med. 1980; 140:864.

Salerno F, Cherashore J, Middleton E. Anaphylactoid reaction to Bromsulphalein. J Med Soc N J. 1963; 60:435–8.

Salix announces statistically significant primary endpoint result for target 3 evaluating the efficacy and safety of repeat treatment with rifaximin 550mg in subjects with irritable bowel syndrome with diarrhea. 1 Jul 2014. Accessed 1 Jul 2014.

Sampson HA, Muñoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al. Symposium on the definition and management of anaphylaxis: Summary report. J Allergy Clin Immunol. 2005; 115:584–91.

Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: Summary report — Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117:391–7.

Sampson HA, Burks AW. Chapter 65: Adverse reactions to foods, in Adkinson NF, Busse WW, Bochner BS, Holgate ST, Simons FER, Lemanske RF, eds. Middleton's Allergy: Principles and Practice, 7th ed. Philadelphia: Mosby; 2009.

Samuel SA. Apparent anaphylactic reaction to zomepirac (Zomax). N Engl J Med. 1981;304(16):978.

Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonesca F. Oral mite anaphylaxis (pancake syndrome) also observed in children. Ann Allergy Asthma Immunol. 2006; 96:755–6.

Sattler J, Hesterberg R, Schmidt U, Crombach M, Lorenz W. Inhibition of intestinal diamine oxidase by detergents: a problem for drug formulations with water insoluble agents applied by the intravenous route? Inflammation Research. 1987; 20:270–3.

Saunders Jr RL, Halpern GM, Gershwin ME. Odor associated idiopathic anaphylaxis. A case report. Allergol et Immunopathol. 1995; 23(1):35–7.

Schatz M. H1-Antihistamines in pregnancy and lactation. In: Simons FER. Histamine and H1-Antihistamines in Allergic Disease. 2nd, revised and expanded ed. New York: Marcel Dekker, Inc.; 2002; 421–436.

Schatz M, Zeiger RS, Falkoff R, Chambers C, Macy E, Mellon MH. Asthma and allergic diseases during pregnancy. In: Adkinson NF, Bochner BS, et al., eds. Middleton's Allergy: Principles and Practice. 7th ed. Philadelphia, PA: Saunders-Elsevier. 2008; 2:1433–1446.

Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol. 2008; 122:261–6.

Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: Case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol. 2006; 96:497–500.

Schocket AL, ed. Clinical Management of Urticaria and Anaphylaxis. New York, NY: Marcel Dekker; 1993.

Schondorf R, Shen W. Syncope: Case studies. Neurol Clin. 2006; 24:215–231.

Schroeder JT. Basophils: Beyond effector cells of allergic inflammation. Adv Immunol. 2009; 101:123–61.

Schroer BC, Fox CC, Hauswirth DW. Skin testing after anaphylaxis to a topical Neosporin preparation [letter]. Ann Allergy Asthma Immunol. 2008; 101:444.

Schwartz J, Dibblee M. The role of IgE in the release of histamine from human gingival mast cells. J Periodontol. 1975; 46:171–7.

Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987; 316:1622–6

Schwartz LB, ed. Neutral Proteases of Mast Cells. Monographs in Allergy, Vol. 27. New York, NY: Karger; 1990.

Schwarz N, Ham Pong A. Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: A case report. Ann Allergy Asthma Immunol. 1996; 77:473–4.

Schwelberger HG. Diamine oxidase (DAO) enzyme and gene. In: Falus A, Grosman N, Darvas Z, eds. Histamine: Biology and Medical Aspects. Budapest: SpringMed Publishing, Ltd.; 2004; 43–52.

Schwelberger HG. Histamine N-methyltransferase (HNMT) enzyme and gene. In: Falus A, Grosman N, Darvas Z, eds. Histamine: Biology and Medical Aspects. Budapest: SpringMed Publishing, Ltd.; 2004; 53–9.

Selye H. The Mast Cells. Washington, DC: Butterworth; 1965.

Shaffer HC, Parsons DJ, Peden DB, Morrell D. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: Case report and literature review. J Am Acad Dermatol. 2006: 54:S210–3.

Shahid H, Salmon JF. Anaphylactic response to topical fluorescein 2% eye drops: a case report. J Med Case Reports. 2010;4(1):27.

Shaikh WA. Allergy to heroin. Allergy. 1990; 45:555–6.

Shannon MW, Borron SW, Burns MJ. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose 4th ed. Philadelphia, PA: Saunders Elsevier; 2007.

Sharma A, Chopra H. Chlorhexidine urticaria: a rare occurrence with a common mouthwash. Indian J Dent Res. 2009; 20:377–9.

Sheehan WJ, Graham D, et al. Higher incidence of pediatric anaphylaxis in northern areas of the United States. J Allergy Clin Immunol. 2009; 124(4):850–852.

Sheffer AL. Unraveling the mystery of idiopathic anaphylaxis. NEJM. 1984; 311(19):1248–1249.

Sheikh J, Saini SS, Kulczycki A, Jr., Dreskin SC. A survey of allergists regarding the association of thyroid autoimmunity with chronic urticaria. J Allergy Clin Immunol. 2009; 123:1173–5.

Shibamoto T, Liu W, Cui S, Zhang W, Takano H, Kurata Y. PAF, rather than histamine, participates in mouse anaphylactic hypotension. Pharmacology. 2008; 82(2):114–120.

Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R. Mast cells: A unique source of renin. Proc Natl Acad Sci. 2004: 101:13607–13612.

Silverstein AM. A History of Immunology. 2nd ed. Adobe Digital ed. Burlington, MA: Academic Press, imprint of Elsevier; 2009.

Simmonds J, Hodges S, Nicol F, Barnett D. Anaphylaxis after oral penicillin. Br Med J. 1978; 2:1404.

Simons CW, Benouni S, Gibbon G, Klaustermeyer W. Severe anaphylactoid shock secondary to gadolinium contrast media. Ann Allergy Asthma Immunol. 2009;103(4):359–60.

Simons FER. Ancestors of Allergy. New York, NY: Global Medical Communications Ltd.; 1994.

Simons FER, Gu X, Johnston LM, Simons KJ. Can epinephrine inhalations be substituted for epineiphrine injection in children at risk for systemic anaphylaxis? Pediatrics. 2000; 106:1040–4.

Simons FER. Histamine and H1-Antihistamines in Allergic Disease. 2nd, revised and expanded ed. New York: Marcel Dekker, Inc.; 2002.

Simons FER. Anaphylaxis: Evidence-based long-term risk reduction in the community. Immunol Allergy Clin N Am. 2007; 27:231–248.

Simons FER. Anaphylaxis in infants: Can recognition and management be improved? J Allergy Clin Immunol. 2007; 120(3):537–540.

Simons FER. Anaphylaxis. J Allergy Clin Immunol 2008; 121:S402-7; quiz S20.

Simons FER. Anaphylaxis: Recent advances in assessment and treatment. J Allergy Clin Immunol. 2009; 124:625–36; quiz 37–8.

Simons FER. Epinephrine auto-injectors: First-aid treatment still out of reach for many at risk of anaphylaxis in the community. Ann Alllergy Asthma Immunol. 2009; 102:403–9.

Simons FER, Clark S, Camargo CA. Anaphylaxis in the community: Learning from the survivors. J Allergy Clin Immunol. 2009; 124:301–6.

Simons FER, Lieberman PL, Read EJ, Edwards ES. Hazards of unintentional injection of epinephrine from autoinjectors: A systematic review. Ann Allergy Asthma Immunol. 2009; 102:282–7.

Simons FER. Anaphylaxis. J Allergy Clin Immunol. 2010; 125:S161–81.

Simons FE, Simons KJ. Epinephrine (adrenaline) in anaphylaxis. Chemical Immunol & Allergy. 2010; 95:211–22.

Simons KJ, Gu X, MacNair KR, Simons FER. Outdated EpiPen®s: Past their prime? [Abstract] J Allergy Clin Immunol. 2000; 105(1, pt 2):S275.

Slater JE, Kaliner M. Effects of sex hormones on basophil histamine release in recurrent idiopathic anaphylaxis. J Allergy Clin Immunol. SEP 1987; 80(3 Pt 1):285–290.

Slavich GM, Way BM, Eisenberger NI, Taylor SE. Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107:14817–22.

Smith MB, Hofmann VC. Anaphylactoid reaction to chymopapain. Anaesthesia. 1989; 44:767–9.

Smith PL, Kagey-Sobotka A, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest. 1980;v66:1072–80.

So YT. Effects of toxins and physical agents on the nervous system: Marine toxins. In: Bradley WG, Daroff RB, et al., eds. Neurology in Clinical Practice. 5th ed. Philadelphia, PA: Butterworth Heinemann Elsevier; 2008; 1682–1686.

Somech R, Seaban-Adel K, Atkinson A, Kirby-Allen M. Evaluation and management of pediatric patients with anaphylactoid reactions to deferoxamine mesylate. Ann Allergy Asthma Immunol. DEC 2007; 99:575–576.

Soykan I, Ertan C, Ozden A. Severe anaphylactic reaction to infliximab: Report of a case. Am J Gastroenterol. 2000; 95:2395–6.

Spitalny KC, Farnham JE, Witherell LE, Vogt RL, Fox RC, Kaliner M, et al. Alpine slide anaphylaxis. N Engl J Med. 1984; 310:1034–7.

Sreevastava D, Tarneja V. Anaphylactic reaction: An overview. MJAFI. 2003; 59:53–6.

Srinivasa MR, Phelan C. Death due to anaphylactic shock after ingestion of Imodium instants (Loperamide). Allergy. 2007; 62:965–6.

Stedman’s Electronic Medical Dictionary, 7.0, version 10.2.

Stein DJ, Kupfer DJ, Schatzberg AF. The American Psychiatric Publishing Textbook Of Mood Disorders. American Psychiatric Publishing; 2005.

Stone JH. Immune complex-mediated small vessel vasculitis. In: Firestein GS, Budd RD, Harris ED, McInnes IB, Ruddy S, Sergent JS. Kelley's Textbook of Rheumatology. 8th ed. Philadelphia, PA: Elsevier; 2008.

Strait RT, Morris SC, Finkelman FD. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest. 2006; 116:833–41.

Stricker WE, Anorve-Lopez E, Reed CE. Food skin testing in patients with idiopathic anaphylaxis. J Allergy Clin Immunol. MAR 1986; 77(3):516–519.

Stuck BA, Blum A, Klimek L, Hörmann K. Millet, a potentially life-threatening allergen. Allergy. APR 2001; 56(4):350. DOI: 10.1034/j.1398-9995.2001.00061.x

Sundström M. Signal Transduction in Mast Cell Migration. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1081. Uppsala, Sweden: Acta Universitatis Upsaliensis; 2001.

Szczeklik A. Analgesics. Chemical Immunol & Allergy. 2010; 95:170–9.

Szebeni J, ed. The Complement System: Novel Roles in Health and Disease. Boston, MA: Kluwer Academic Publishers; 2004.

Previous (P — R) Go to top of page Next (T — V)


Page last updated: July 1, 2014

 
All information contained in this site is one layperson's interpretation of medical journal articles, textbooks, seminars, presentations, and other materials. Nothing that is stated here should carry more weight than the informed and considered opinions of your own highly trained and qualified medical caregivers. The author of this site is not a doctor and has absolutely no authority to prescribe or diagnose.

The idiopathic anaphylaxis information center: A resource for people with IA and other mast cell disorders
HomeAnaphylaxisArticlesFAQsBlogAbout usReferencesLinks
Site helpSite mapContact Webmaster